DKMA Update March 2018

28 March 2018

This newsletter features the following articles:

  • Evidence on the agenda
  • The SmPC for tramadol to be changed
  • Inspection of the sale of over-the-counter medicines outside pharmacies
  • Do not use Xofigo for treatment of prostate cancer in combination with Zytiga and the anti-inflammatory agents prednisone/prednisolone
  • Rare but possible risk of liver injury in the treatment of fibroids with the medicine Esmya
  • Multiple sclerosis medicine Zinbryta removed from the market

Short news:

  • New status report on biological medicines and biosimilars
  • Scientific advice to promote research and innovation
  • Short film about the medicinal cannabis pilot programme


DKMA Update March 2018 (pdf)